Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,625 | 21 | 78.8% |
| Food and Beverage | $9,336 | 566 | 19.5% |
| Travel and Lodging | $615.37 | 2 | 1.3% |
| Education | $191.49 | 44 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Assertio Therapeutics, Inc. | $17,562 | 36 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $16,888 | 143 | $0 (2021) |
| Depomed, Inc. | $6,966 | 12 | $0 (2017) |
| Daiichi Sankyo Inc. | $1,147 | 86 | $0 (2019) |
| Allergan, Inc. | $495.94 | 35 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $384.58 | 32 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $383.56 | 13 | $0 (2021) |
| SCILEX PHARMACEUTICALS INC. | $278.97 | 25 | $0 (2020) |
| Pernix Therapeutics Holdings, Inc. | $258.48 | 29 | $0 (2018) |
| Nevro Corp. | $239.78 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $1,053 | 50 | Biohaven Pharmaceuticals, Inc. ($363.99) |
| 2020 | $1,010 | 85 | Collegium Pharmaceutical, Inc. ($174.18) |
| 2019 | $1,612 | 126 | Collegium Pharmaceutical, Inc. ($246.88) |
| 2018 | $21,514 | 192 | Assertio Therapeutics, Inc. ($17,407) |
| 2017 | $22,579 | 180 | Collegium Pharmaceutical, Inc. ($13,947) |
All Payment Transactions
633 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/13/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Gastroenterology | ||||||
| 06/23/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: PRIMARY CARE | ||||||
| 06/23/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: PRIMARY CARE | ||||||
| 06/22/2021 | Almatica Pharma LLC | NAPRELAN (Drug), GRALISE | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: ANALGESIC | ||||||
| 06/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2021 | RedHill Biopharma Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Opioid Antagonist | ||||||
| 06/10/2021 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $36.16 | General |
| Category: Pain Management | ||||||
| 06/08/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $66.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/27/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.12 | General |
| Category: Neurology | ||||||
| 05/21/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: Opioid Analgesic | ||||||
| 05/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Gastroenterology | ||||||
| 05/12/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: PRIMARY CARE | ||||||
| 05/06/2021 | Almatica Pharma LLC | NAPRELAN (Drug), GRALISE | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: ANALGESIC | ||||||
| 05/06/2021 | Almatica Pharma LLC | NAPRELAN (Drug), GRALISE | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: ANALGESIC | ||||||
| 05/05/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $12.18 | General |
| Category: Neurology | ||||||
| 04/21/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: PRIMARY CARE | ||||||
| 04/21/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: PRIMARY CARE | ||||||
| 04/21/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 10 | 658 | 1,212 | $286,350 | $89,886 |
| 2020 | 17 | 1,552 | 3,676 | $939,883 | $276,411 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2020 | 17 | 24 | $2,424 | $64.73 | 2.7% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2020 | 60 | 103 | $10,403 | $9.36 | 0.1% |
About Dr. Phillip Fyman, MD
Dr. Phillip Fyman, MD is a Interventional Pain Medicine healthcare provider based in Syosset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528050051.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Phillip Fyman, MD has received a total of $47,768 in payments from pharmaceutical and medical device companies, with $1,053 received in 2021. These payments were reported across 633 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($37,625).
As a Medicare-enrolled provider, Fyman has provided services to 2,210 Medicare beneficiaries, totaling 4,888 services with total Medicare billing of $366,297. Data is available for 2 years (2020–2021), covering 27 distinct procedure/service records.
Practice Information
- Specialty Interventional Pain Medicine
- Location Syosset, NY
- Active Since 08/19/2005
- Last Updated 12/14/2009
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1528050051
Products in Payments
- Gralise (Drug) $24,321
- Xtampza ER (Drug) $16,159
- Morphabond ER (Drug) $735.46
- XTAMPZA (Drug) $561.41
- Movantik (Drug) $443.64
- NURTEC ODT (Drug) $383.56
- ZOHYDRO ER (Drug) $258.48
- BOTOX (Biological) $229.34
- RELISTOR (Drug) $207.50
- MOVANTIK (Drug) $189.88
- Horizant (Drug) $189.49
- Senza Spinal Cord Stimulation System (Device) $173.78
- Zipsor (Drug) $160.93
- Dayvigo (Drug) $153.91
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $151.55
- RELISTOR ORAL (Drug) $149.25
- UBRELVY (Drug) $143.83
- Evzio (Drug) $131.73
- ZTLido (Drug) $127.42
- BELBUCA (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.